文献速递泌尿生殖与妇科肿瘤放疗

宫颈癌体外放疗与图像引导自适应近距离放疗后阴道11点法与体积剂量与晚期阴道并发症的关系

Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy.
PubMed 文献 · Radiother Oncol · 2022-07-15

回顾性队列纳入97例根治性放疗后完全缓解≥12个月的宫颈癌患者,中位随访20个月,3级阴道狭窄发生率22.7%。年龄、肿瘤大小及阴道下三分之一受累与阴道毒性相关;PIBS+2、PIBS、PIBS-2、D+5、D2cc在1-3级狭窄间有显著差异,作者认为PIBS+2累积剂量≤55 Gy3、PIBS-2≤5 Gy3、D+5≤65 Gy3可能将3级狭窄风险降至15-20%以下。

要点

  • 97例宫颈癌根治性放疗后完全缓解≥12个月患者,中位随访20个月,3级阴道狭窄发生率22.7%。
  • 年龄、分期、初始肿瘤大小及阴道受累在1-3级阴道狭窄患者间有显著差异。
  • PIBS+2、PIBS、PIBS-2、D+5、D2cc在1-3级狭窄间有显著差异并显示显著概率单位系数。

核心结论

  • 年龄、肿瘤大小及阴道下三分之一受累与阴道毒性发生率显著相关。
  • 作者认为PIBS+2累积剂量≤55 Gy3、PIBS-2≤5 Gy3、D+5≤65 Gy3可能将3级阴道狭窄风险降至15-20%以下。

研究设计与样本

  • 回顾性队列研究,纳入根治性宫颈癌放疗后完全缓解至少12个月的患者97例,中位随访20个月。
  • 入组时进行额外阴道检查及患者评分问卷评估阴道狭窄,并行阴道11点法与体积剂量的回顾性剂量学分析及描述性和概率单位分析。

主要发现

  • 3级阴道狭窄发生率为22.7%。
  • 1-3级阴道狭窄患者间年龄、分期、初始肿瘤大小及阴道受累比较有显著差异。
  • PIBS+2、PIBS、PIBS-2、D+5和D2cc在1-3级阴道狭窄间均有显著差异,并显示显著的概率单位系数。
  • 2级狭窄患者侧方剂量点显著更高,但概率单位系数为负,未能建立因果推断。
  • 事后估计分析得出PIBS+2发生15%和20%概率3级阴道狭窄的有效剂量(ED15和ED20)分别为57.4和111 Gy3;PIBS-2的ED20为7 Gy3;D+5的ED10、ED15和ED20分别为52.2、66.6和78 Gy3。

关键数值与推荐

  • PIBS+2的ED15为57.4 Gy3、ED20为111 Gy3。
  • PIBS-2的ED20为7 Gy3。
  • D+5的ED10为52.2 Gy3、ED15为66.6 Gy3、ED20为78 Gy3。
  • 作者提出PIBS+2累积剂量≤55 Gy3、PIBS-2≤5 Gy3、D+5≤65 Gy3可能将3级阴道狭窄风险降至15-20%以下。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the vaginal 11-point and volumetric dose-toxicity relationships in definitive cervical cancer radiotherapy. METHODS: A retrospective cohort study of patients with cervical cancer with a complete response of at least 12 months was performed. Additional per vaginal examinations and patient-scoring questionnaires on the date of patient enrolment were assessed for vaginal strictures. Retrospective dosimetric analysis of vaginal 11-point and volumetric doses was performed with descriptive and probit analyses to investigate dose-toxicity relationships. RESULTS: Ninety-seven patients were included in the study, with a 20-month median follow-up. The incidence rate of grade 3 vaginal strictures was 22.7%. A comparison between patients with grade 1-3 vaginal strictures revealed significant differences in age, stage, initial tumour size, and vaginal involvement. PIBS + 2, PIBS, PIBS-2, D + 5, and D2cc were all significantly different among grade 1-3 vaginal strictures and showed significant probit coefficients. The lateral dose points were significantly higher in grade 2 strictures, but negative probit coefficients failed to establish causal inferences. Post-estimation analyses yielded effective doses (ED) for 15% and 20% probability of grade 3 vaginal strictures (ED15 and ED20) for PIBS + 2 at 57.4 and 111 Gy3, respectively. PIBS-2 yielded an ED20 of 7 Gy3. D + 5 yielded positive ED10, ED15, and ED20 values of 52.2, 66.6, and 78 Gy3, respectively. CONCLUSIONS: This study showed a significant relationship between age, tumour size, and lower-third vaginal involvement with the incidence of vaginal toxicity. The goal of a cumulative radiotherapy dose of ≤ 55 Gy3 to PIBS + 2, ≤5 Gy3 to PIBS-2, and ≤ 65 Gy3 to D + 5 points may reduce the risk of grade 3 vaginal stenosis to less than 15-20%.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Dankulchai P, Harn-Utairasmee P, Prasartseree T, et al. Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy. Radiother Oncol. 2022. PMID: 35839936. doi:10.1016/j.radonc.2022.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。